POLYNEURON
Polyneuron is a developer of novel therapeutics intended to facilitate the treatment of antibody-mediated autoimmune diseases. The company's biodegradable glycopolymers-based therapeutics selectively eliminate the pathological autoantibodies, while leaving the rest of the immune system intact, enabling medical practitioners to treat patients with immune disorders in a safe and effective manner.
POLYNEURON
Industry:
Biotechnology Communities Medical Medical Device
Founded:
2014-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.polyneuron.com
Total Employee:
1+
Status:
Active
Contact:
+41788371011
Email Addresses:
[email protected]
Total Funding:
43.34 M CHF
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Agenus
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
CVRx
CVRx is a medical device company developing implantable technology for the treatment of high blood pressure.
LYSOGENE
Lysogene is a pioneer in the basic research and clinical development of gene therapy for neurodegenerative disorders.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Senseonics
Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.
Sigmascreening
At Sigmascreening, an Amsterdam based medical device company, they focus on the development of new products in the area of breast cancer
Current Advisors List
Current Employees Featured
Founder
Investors List
New Enterprise Associates
New Enterprise Associates investment in Series A - POLYNEURON
HBM Healthcare Investments
HBM Healthcare Investments investment in Series A - POLYNEURON
Sofinnova Partners
Sofinnova Partners investment in Series A - POLYNEURON
New Enterprise Associates
New Enterprise Associates investment in Series A - POLYNEURON
Sofinnova Partners
Sofinnova Partners investment in Series A - POLYNEURON
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Seed Round - POLYNEURON
EVA Basel
EVA Basel investment in Seed Round - POLYNEURON
BaseLaunch
BaseLaunch investment in Grant - POLYNEURON
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Seed Round - POLYNEURON
EVA Basel
EVA Basel investment in Seed Round - POLYNEURON
Key Employee Changes
Date | New article |
---|---|
2020-10-06 | Polyneuron Appoints Aled Williams as Chief Business Officer |
Official Site Inspections
http://www.polyneuron.com
- Host name: lb-182-253.above.com
- IP address: 103.224.182.253
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
More informations about "POLYNEURON"
Organizational Chart – polynetron_EN
Organizational chart of Polynetron. For the past 30 years, Polynetron has faced many difficulties and overcome them with its passion and challenging spirit, and has become a leader in the coating agent field. ...See details»
Polyneuron Pharmaceuticals - The Org
Polyneuron is a growing Basel-based biotechnology company active in the area of autoimmune disease treatments. The company was founded in 2014 as a spinout company from the …See details»
polynetron – 코팅사업의 토탈 솔루션 (주)폴리네트론
Home Contact. Primary Menu. 회사소개. 회사개요; 대표이사 인사말; 연혁; 조직도See details»
Polyneuron Pharmaceuticals Company Profile | Management and …
Polyneuron Pharmaceuticals Profile and History. Polyneuron Pharmaceuticals is pioneering a novel therapeutic approach for the effective and safe treatment of antibody-mediated immune …See details»
Polyneuron CEO and Key Executive Team | Craft.co
Polyneuron's Co-Founder & Chief Executive Officer is Ruben Herrendorff. Other executives include Barker M.D., Chief Medical Officer; Pascal Haenggi, Co-Founder, Chief Scientific …See details»
POLYNEURON - Contacts, Employees, Board Members, Advisors
Edit Board Member and Advisor Profiles Section. Number of Board Member and Advisor Profiles 2. POLYNEURON has 2 board members and advisors, including Emil Bujak.See details»
Leadership Team - The Org
About. Polyneuron Pharmaceuticals' Leadership Team includes Juergen Jaeger and 4 others.See details»
Board of Directors - The Org
Polyneuron Pharmaceuticals' Board of Directors includes Ben Machielse and 3 others.See details»
Polyneuron Pharmaceuticals - VentureRadar
Website: http://polyneuron.com/ Polyneuron is pioneering a novel therapeutic approach for the effective and safe treatment of antibody-mediated autoimmune diseases ...See details»
Polynetron Co., Ltd. Company Profile - Dun & Bradstreet
Polynetron Co., Ltd. D&B Business Directory HOME / BUSINESS DIRECTORY / MANUFACTURING / CHEMICAL MANUFACTURING / SOAP, CLEANING COMPOUND, …See details»
Polyneuron’s Competitors, Revenue, Number of Employees
Polyneuron’s Profile, Revenue and Employees. Polyneuron is a Switzerland-based pharmaceutical company that develops and commercializes biodegradable glycopolymers for …See details»
POLYNEURON - Recent News & Activity - Crunchbase
Oct 6, 2020 Polyneuron is a pharmaceutical company, committed to the development of a new drug class for the treatment of autoimmune disorders.See details»
(주)폴리네트론 2021년 기업정보 | 사원수 26명, 근무환경, 복리후생 …
(주)폴리네트론 회사 소개, 기업정보, 근무환경, 복리후생, 하는 일, 회사위치, 채용정보, 연봉정보 등을 사람인에서 확인해보세요. (saramin.co.kr)See details»
Polyneuron Pharmaceuticals - Switzerland Innovation Park Basel …
SIP – Swiss Innovation Park Switzerland. Polyneuron is pioneering a novel therapeutic approach for the effective and safe treatment of antibody-mediated autoimmune diseases of the nervous …See details»
CEO and Executive Team - The Org
Polyneuron Pharmaceuticals' CEO and Executive Team includes Pascal Haenggi and 2 others.See details»
Polyneuron Pharmaceuticals - VentureRadar
Similar Companies: ABLEVIA biotech GmbH Austria Privately Held Ablevia's proprietary platform technology enables selective targeting of harmful antibodies by infusible therapeutics. We …See details»
POLYNEURON - Updates, News, Events, Signals & Triggers
Polyneuron is a pharmaceutical company, committed to the development of a new drug class for the treatment of autoimmune disorders.See details»
Introduction of our Technology Research Institute - polynetron
Since its foundation, the Advanced Material Technology Research Institute of Polynetron has consistently developed for the past 30 years. With the founder’s belief that technology is the …See details»
Polyneuron Pharmaceuticals AG - Facebook
Polyneuron Pharmaceuticals AG. 105 likes. Polyneuron is an early stage Swiss pharmaceutical company that is committed to the development of new drugs for the treatment of autoimmune …See details»
2024년 폴리네트론 채용 기업정보 - 인크루트
자본총계 매출액 순이익 결산일; 32억 2,597만원: 132억 4,334만원: 1억 7,541만원: 2023.12.31See details»